Filing Details
- Accession Number:
- 0001171843-25-002086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-08 09:30:55
- Reporting Period:
- 2025-04-07
- Filing Date:
- 2025-04-08
- Accepted Time:
- 2025-04-08 09:30:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1738021 | Compass Therapeutics Inc. | CMPX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2032625 | Jonathan Anderman | C/O Compass Therapeutics, Inc. 80 Guest Street, Suite 601 Boston MA 02135 | Gen Counsel & Corporate Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-07 | 20,000 | $1.54 | 21,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
